AgomAb Therapeutics NV (AGMB) Receivables - Other (2024 - 2025)
Agomab Therapeutics' Receivables - Other came in at $2.47 million for Q4 2025, up 105.3% from $1.2 million a year earlier.
Powered by 
Analysis
AgomAb Therapeutics NV (AGMB) Receivables - Other (2024 - 2025) Analysis & Trends
At the end of FY2025, Agomab Therapeutics' Receivables - Other was $2.4 million, up 96.7% from FY2024.
- Going back by year, Receivables - Other was $1.22 million in FY2024.
Peer Set
Peer Comparison
API Access
AgomAb Therapeutics NV Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();